9955 Stock Overview
An investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 9955 from our risk checks.
ClouDr Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.80 |
52 Week High | HK$7.83 |
52 Week Low | HK$1.57 |
Beta | 0.36 |
11 Month Change | 0.56% |
3 Month Change | -47.06% |
1 Year Change | -74.75% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -93.62% |
Recent News & Updates
Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper
Jun 09Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely
Apr 24Recent updates
Take Care Before Jumping Onto ClouDr Group Limited (HKG:9955) Even Though It's 27% Cheaper
Jun 09Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely
Apr 24ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward
Apr 17ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate
Feb 20An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued
Oct 07Shareholder Returns
9955 | HK Healthcare | HK Market | |
---|---|---|---|
7D | 12.5% | 1.4% | -1.7% |
1Y | -74.8% | -30.8% | -5.9% |
Return vs Industry: 9955 underperformed the Hong Kong Healthcare industry which returned -32.2% over the past year.
Return vs Market: 9955 underperformed the Hong Kong Market which returned -6.7% over the past year.
Price Volatility
9955 volatility | |
---|---|
9955 Average Weekly Movement | 8.0% |
Healthcare Industry Average Movement | 5.7% |
Market Average Movement | 6.5% |
10% most volatile stocks in HK Market | 13.7% |
10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 9955's share price has been volatile over the past 3 months.
Volatility Over Time: 9955's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | 1,522 | Ming Kuang | www.cloudr.cn |
ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company’s integrated in-hospital solution offers chronic condition management solution to hospitals including hospital SaaS and proprietary artificial intelligence of things devices; and integrated out-of-hospital solution consists of pharmacy solution and individual chronic condition management solution. It also offers pharmacy solution, which includes pharmacy SaaS, pharmacy supplies, and sells stock keeping units based on its SaaS network in pharmacies; pharmacy SaaS that enables in-store, real-time online consultation, and prescription services; identifies pharmacy supplies sales opportunities based on the insights generated from prescription services; and retail and inventory management functions for pharmacies.
ClouDr Group Limited Fundamentals Summary
9955 fundamental statistics | |
---|---|
Market cap | HK$1.06b |
Earnings (TTM) | -HK$352.64m |
Revenue (TTM) | HK$4.03b |
0.3x
P/S Ratio-3.0x
P/E RatioIs 9955 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9955 income statement (TTM) | |
---|---|
Revenue | CN¥3.69b |
Cost of Revenue | CN¥2.78b |
Gross Profit | CN¥909.38m |
Other Expenses | CN¥1.23b |
Earnings | -CN¥323.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.55 |
Gross Margin | 24.64% |
Net Profit Margin | -8.75% |
Debt/Equity Ratio | 24.8% |
How did 9955 perform over the long term?
See historical performance and comparison